Skip to main content

Immunomic Therapeutics

Lancaster, United States

Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines.

$6.5M raised
Jun 2025
Venture - Series Unknown

Top Investors

Life Sciences Greenhouse of PennsylvaniaBrainchild HoldingsKeiretsu Forum NorthwestMid Atlantic Bio AngelsMinority Angel Investor Network

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Immunomic Therapeutics

How much funding has Immunomic Therapeutics raised?
Immunomic Therapeutics has raised $6.5M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2025.
Who are Immunomic Therapeutics's investors?
Immunomic Therapeutics's investors include Life Sciences Greenhouse of Pennsylvania, Brainchild Holdings, Keiretsu Forum Northwest, Mid Atlantic Bio Angels, Minority Angel Investor Network.
Where is Immunomic Therapeutics headquartered?
Immunomic Therapeutics is headquartered in Lancaster, United States.
What does Immunomic Therapeutics do?
Immunomic Therapeutics is a development stage biotechnology company that develops lysosomal associated membrane protein-based vaccines.
What stage is Immunomic Therapeutics at?
Immunomic Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Immunomic Therapeutics — Funding & Investors." VCBacked, June 2, 2025, https://www.vcbacked.co/company/immunomic-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2025). Immunomic Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/immunomic-therapeutics
Wikipedia (cite web)
{{cite web |title=Immunomic Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/immunomic-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .